1Li B,Zhu WL,Chen KX,et al. Advances in the study of berberine and its der ivatives[J]. Yao Xue Xue Bao, 2008, 43 (8) :773-778. 被引量：1
2Lee TS, Pan CC, Peng CC, et al. Anti-atherogenic effect of bcrberine on LXRalpha-ABCAl-dependent cholesterol efflux in macrophages[J]. J of Cell Biochemistry, 2010, 111 ( 1 ) : 104-110. 被引量：1
3Cok A, Plaisier C, Salie MJ, et al. Berberine acutely activates the glucose transport activity of GLUT1 [J]. Biochimie, 2011, 93(7):1187-1192. 被引量：1
4Chen Y,Wang Y, Zhang S. Berberine improves glucose home- ostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistaneeEJ]. ISRN Endocrinol,2011,156(9):1101-1109. 被引量：1
5Wang XH, Jiang SM, Sun QW. Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes[J]. Exp Biol Med,2011,236(7):859-866. 被引量：1
6Yan F, Wang LH, Shi Y, et al. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice[J]. Am J of physiol Gastrointest Liver Physiol, 2011,302(5): 504-514. 被引量：1
7Park KS, Kim J B, Bae J, et al. Berberine Inhibited the Growth of Thyroid Cancer Cell Lines 8505C and TPCI[J]. Yonsei Med J,2012,53(2) :346-351. 被引量：1
8Xu D,Yang W,Zhou CH,et al. Preventive Effects of Berberine on Glucocorticoid-Induced Osteoporosis in Rats[J]. Planta Med, 2010,76(16) : 1809-1813. 被引量：1
10Liu YH, Zhu X, Zhou D, et al. pH Sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system[J]. Drug Dev Ind Pharm,2011,37(7):868-874. 被引量：1
6Rnaksiz F, Robinson J R, Rheologieal. Mucoadhesive and release properties of pluronie F-127 gel and pluronie F-127/ polyearbophil mixed gel systems [J]. Pharmazie, 2005, 60: 518-523. 被引量：1
7Wei G, Xu H, Ding P T, et al. Thermosetting gels with modulated gelation temperature for ophthalmic use the rheological and gamma seintigraphie studies [J]. J Control Release, 2002, 83 : 65-74. 被引量：1
8Hagerstrom H, Paulsson M, Edsman K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheologieal method[J]. Eur J Pharm Sci, 2000, 9: 301-309. 被引量：1
9El-Kamel A H. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timololmaleate [J]. Int J Pharm, 2002, 241(1): 47-55. 被引量：1
10Kaur I P, Kanwar M. Ocular preparations: the formulation approach [J]. Drug Devel Indu Pharm, 2002, 28(5):473- 493. 被引量：1
